Information for the public
Roflumilast (Daxas) is available on the NHS. It is a possible treatment for severe chronic obstructive pulmonary disease in adults with chronic bronchitis, if:
- symptoms have suddenly got worse at least 2 times over the last 12 months and
- inhalers are being used (containing a long-acting antimuscarinic inhaler, a long-acting beta-2 agonist inhaler and a corticosteroid inhaler).
Roflumilast is an additional treatment, to be taken as well as the inhalers. It has to be started by a specialist in respiratory medicine.
If you are not eligible for roflumilast but are already taking it, you should be able to continue until you and your doctor decide when best to stop.
Is this treatment right for me?
Your healthcare professionals should give you clear information, talk with you about your options and listen carefully to your views and concerns. Your family can be involved too, if you wish. Read more about making decisions about your care.
Questions to think about
- How well does it work compared with other treatments?
- What are the risks or side effects? How likely are they?
- How will the treatment affect my day-to-day life?
- What happens if the treatment does not work?
- What happens if I do not want to have treatment? Are there other treatments available?
Information and support
NHS Choices may be a good place to find out more.
This organisation can give you advice and support:
- British Lung Foundation, 03000 030 555
NICE is not responsible for the quality or accuracy of any information or advice provided by these organisations.
ISBN: 978-1-4731-2610-7
This page was last updated: